Trial intelligence / Profile preview

Metformin and blood glucose fluctuation in type 2 diabetes

ChiCTR-TRC-12002505Phase 4Completed

Sponsor
First Affiliated Hospital of Chongqing Medical University
Start
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoints: Height, Weight and 8 more. Started Oct 2012; status: completed.

02

Drugs

metformin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on ChiCTR-TRC-12002505.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002505.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call